More cases a day, reports already written
C-Encode builds software for medical imaging workflows: patient intake, digital worksheets, and reports that arrive pre-populated from the scanner and prior exams, already following the current guideline. Built by engineers and clinicians, working with your PACS and your report templates.
29
DXA scanners live
Running in production today, not in pilot
6,134+
BMD reports delivered
Produced in production to date, not in testing
36+
Languages supported
Patients answer in their own language, on site
DXA Encode
Bone mineral density, from the patient arriving to a report ready for signature. CAROC and FRAX are both built in, the technologist worksheet fills itself from the scanner and prior exams, and the draft comes out CAR-aligned in your site’s own template, straight into PACS and your dictation software.
40% less tech time per case
25 min → 15 min per patient
Up to 56% more cases scanned
18 → 28 cases per day
90% faster reporting
5 min → less than 30s
Report
Patient
SAMPLE, PATIENT
MRN
SMP-100412
Accession
1915199576004821
Date of birth
1951-02-14 (age 75)
Sex
Female
Study date
2026-06-12
Bone Mineral Density
DENSITY (g/cm²) | T-SCORE | Z-SCORE | DENSITY PRIOR (g/cm²) | CHANGE (g/cm²) | CHANGE (%) | |
|---|---|---|---|---|---|---|
| Spine L2-L4. | 0.835 | -2.5 | -0.2 | 0.874 | -0.039 | -4.5 |
| Right Femoral Neck. | 0.631 | -2.6 | -1.1 | N/A | N/A | N/A |
| Right Total Hip. | 0.590 | -3.4 | -1.9 | 0.615 | -0.025 | -4.1 |
DIAGNOSTIC CATEGORY: Osteoporosis.
10-YEAR MAJOR OSTEOPOROTIC FRACTURE RISK (FRAX): 20.0%
RISK FACTORS: Glucocorticoids (Chronic). Secondary Osteoporosis. Cortisone (50 mg) 2025-01 - (ongoing). Aromatase inhibitors.
BONE-ACTIVE DRUG THERAPY: No.
LIMITATIONS: Vertebra(e) has/have been excluded from analysis as the T-score(s) is/are at least one standard deviation greater than the T-score of the vertebra with the next highest value. The left hip was not assessed due to orthopedic intervention. Fracture risk is likely underestimated because an osteoporotic T-score at the lumbar spine, femoral neck, or total hip is not accounted for in FRAX.
RECOMMENDATIONS: Pharmacotherapy is recommended as per the 2023 Osteoporosis Canada guideline.
FOLLOW-UP: 1 year, given significant interval bone loss.
LSC (least significant change) at Westview Imaging Centre: Lumbar Spine - 0.031 gm/cm² Total Hip - 0.019 gm/cm²
A real report from DXA Encode, shown in full. Nothing here was typed by hand.
How it works
The same three steps behind every product we build, whichever modality it is built around.
Getting the data in
Measurements already sit in the DICOM SR. Reading them directly means nobody re-types a value.
The worksheet
Priors come forward and change is calculated, so most of the appointment becomes a review.
The report
The draft arrives written with the current guideline applied. The radiologist signs rather than composes.
Guidelines change; we track them. Updates to the logic, the recommended treatment and the follow-up intervals arrive ready for your approval, so every report reflects current best practice without anyone having to re-learn a template.
Next from C-Encode
The same method built around another modality, its guidelines and its reporting standards.
OB Encode
Obstetric ultrasound. Structured trimester worksheets with biometry, fluid and Doppler mapped from the DICOM SR, growth plotted against priors, and completeness enforced against reporting standards.
Ask about early access